Alzheimer’s takes Another Hit as Pfizer Ends Research in this Area
The Alzheimer’s disease (“AD”) area is in focus once again with Pfizer Inc. PFE saying that it will be dropping its plans to develop treatments for Alzheimer’s and Parkinson’s disease. According to news sources, Pfizer expects its decision to result in the elimination of 300 positions from the neuroscience discovery and early development programs. […]